Emmett H Kennady, Darren J Bryk, Marwan M Ali, Sarah J Ratcliffe, Indika V Mallawaarachchi, Bahrom J Ostad, Hamza M Beano, Christopher C Ballantyne, Sarah C Krzastek, Matthew B Clements, Mikel L Gray, David E Rapp, Nicolas M Ortiz, Ryan P Smith
{"title":"Low-intensity shockwave therapy improves baseline erectile function: a randomized sham-controlled crossover trial.","authors":"Emmett H Kennady, Darren J Bryk, Marwan M Ali, Sarah J Ratcliffe, Indika V Mallawaarachchi, Bahrom J Ostad, Hamza M Beano, Christopher C Ballantyne, Sarah C Krzastek, Matthew B Clements, Mikel L Gray, David E Rapp, Nicolas M Ortiz, Ryan P Smith","doi":"10.1093/sexmed/qfad053","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Low-intensity shockwave therapy for erectile dysfunction is emerging as a promising treatment option.</p><p><strong>Aim: </strong>This randomized sham-controlled crossover trial assessed the efficacy of low-intensity shockwave therapy in the treatment of erectile dysfunction.</p><p><strong>Methods: </strong>Thirty-three participants with organic erectile dysfunction were enrolled and randomized to shockwave therapy (n = 17) or sham (n = 16). The sham group was allowed to cross over to receive shockwave therapy after 1 month.</p><p><strong>Outcomes: </strong>Primary outcomes were the changes in Sexual Health Inventory for Men (SHIM) score and Erection Hardness Score at 1 month following shockwave therapy vs sham, and secondary outcomes were erectile function measurements at 1, 3, and 6 months following shockwave therapy.</p><p><strong>Results: </strong>At 1 month, mean SHIM scores were significantly increased in the shockwave therapy arm as compared with the sham arm (+3.0 vs -0.7, <i>P</i> = .024). Participants at 6 months posttreatment (n = 33) showed a mean increase of 5.5 points vs baseline (<i>P</i> < .001), with 20 (54.6%) having an increase ≥5. Of the 25 men with an initial Erection Hardness Score <3, 68% improved to a score ≥3 at 6 months. When compared with baseline, the entire cohort demonstrated significant increases in erectile function outcomes at 1, 3, and 6 months after treatment.</p><p><strong>Clinical implications: </strong>In this randomized sham-controlled crossover trial, we showed that 54.6% of participants with organic erectile dysfunction met the minimal clinically important difference in SHIM scores after treatment with low-intensity shockwave therapy.</p><p><strong>Strengths and limitations: </strong>Strengths of this study include a sham-controlled group that crossed over to treatment. Limitations include a modest sample size at a single institution.</p><p><strong>Conclusions: </strong>Low-intensity shockwave therapy improves erectile function in men with erectile dysfunction as compared with sham treatment, which persists even 6 months after treatment.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov NCT04434352.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"11 5","pages":"qfad053"},"PeriodicalIF":2.6000,"publicationDate":"2023-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642534/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexual Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/sexmed/qfad053","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Low-intensity shockwave therapy for erectile dysfunction is emerging as a promising treatment option.
Aim: This randomized sham-controlled crossover trial assessed the efficacy of low-intensity shockwave therapy in the treatment of erectile dysfunction.
Methods: Thirty-three participants with organic erectile dysfunction were enrolled and randomized to shockwave therapy (n = 17) or sham (n = 16). The sham group was allowed to cross over to receive shockwave therapy after 1 month.
Outcomes: Primary outcomes were the changes in Sexual Health Inventory for Men (SHIM) score and Erection Hardness Score at 1 month following shockwave therapy vs sham, and secondary outcomes were erectile function measurements at 1, 3, and 6 months following shockwave therapy.
Results: At 1 month, mean SHIM scores were significantly increased in the shockwave therapy arm as compared with the sham arm (+3.0 vs -0.7, P = .024). Participants at 6 months posttreatment (n = 33) showed a mean increase of 5.5 points vs baseline (P < .001), with 20 (54.6%) having an increase ≥5. Of the 25 men with an initial Erection Hardness Score <3, 68% improved to a score ≥3 at 6 months. When compared with baseline, the entire cohort demonstrated significant increases in erectile function outcomes at 1, 3, and 6 months after treatment.
Clinical implications: In this randomized sham-controlled crossover trial, we showed that 54.6% of participants with organic erectile dysfunction met the minimal clinically important difference in SHIM scores after treatment with low-intensity shockwave therapy.
Strengths and limitations: Strengths of this study include a sham-controlled group that crossed over to treatment. Limitations include a modest sample size at a single institution.
Conclusions: Low-intensity shockwave therapy improves erectile function in men with erectile dysfunction as compared with sham treatment, which persists even 6 months after treatment.
期刊介绍:
Sexual Medicine is an official publication of the International Society for Sexual Medicine, and serves the field as the peer-reviewed, open access journal for rapid dissemination of multidisciplinary clinical and basic research in all areas of global sexual medicine, and particularly acts as a venue for topics of regional or sub-specialty interest. The journal is focused on issues in clinical medicine and epidemiology but also publishes basic science papers with particular relevance to specific populations. Sexual Medicine offers clinicians and researchers a rapid route to publication and the opportunity to publish in a broadly distributed and highly visible global forum. The journal publishes high quality articles from all over the world and actively seeks submissions from countries with expanding sexual medicine communities. Sexual Medicine relies on the same expert panel of editors and reviewers as The Journal of Sexual Medicine and Sexual Medicine Reviews.